Company / AR per Share
Gilead Sciences AR per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest AR per Share
$3.94
FY2025
5-year range
$3.55 / $3.94
FY2021-FY2025
Trend
+11.2%
vs FY2024
Sector context
#27 of 113
Health Care
What the data says
Gilead Sciences's ar per share of $3.94 is higher than 76% of companies in the Health Care sector (FY2025). AR per Share returned to growth in FY2025 after 2 years of decline, reaching $3.94.
Based on SEC 10-K filings.
3.94 in FY2025 with a 5-year CAGR of +0.4%. Top quartile in the Health Care sector.
Improved from $3.74 to $3.94 over the past 2 years.
Health Care sector context is included.
AR per Share over time
Growth rates
- 3-Year CAGR
- +1.2%
- 5-Year CAGR
- +0.4%
- 10-Year CAGR
- -
Sector benchmark
Top 24% in Health CareTop 24% of 113This company $3.94 Sector average $28.83
▼
-86.3% below sector average
Key checks
Key Insights
- In FY2025, ar per share increased 11.2% year-over-year.
- Ranks #27 out of 113 companies in the Health Care sector.
- Lowest ar per share in the period was in FY2018.
Company context
Key Data Points
- Strong profit margin: 27.9%
- Strong return on equity: 37.6%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | AR per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.94 | +11.2% |
| FY2024 | $3.55 | -5.1% |
| FY2023 | $3.74 | -1.9% |
| FY2022 | $3.81 | +6.3% |
| FY2021 | $3.58 | -7.3% |
| FY2020 | $3.86 | +38.3% |
| FY2019 | $2.79 | +9.8% |
| FY2018 | $2.54 | -13.5% |
| FY2017 | $2.94 | -7.4% |
| FY2016 | $3.17 | -18.7% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026